Skip to main content
. 2016 Jul 25;5(4):167–173. doi: 10.1530/EC-16-0038

Table 2.

Characteristics including previous treatment and hormone substitution in 23 patients with acromegaly.

Patients (n = 23)
Median (range)
Men/women (n) 10/13
Current age (years) 68.5 (34–81)
Age at diagnosis (years) 49.5 (28–72)
Years since diagnosis 13.5 (1–38)
Surgery (no of patients) 16
Surgery (quantity/patient) 1 (0–5)
Radiotherapy (n) 3
Somatostatin therapy (n) 22
Duration of somatostatin therapy (years) 13 (1–27)
Dopaminagonist (n) 5
GH-receptor antagonist (n) 2
GH therapy (n) 0
Testosterone substitution (n) 4
Thyroxine substitution (n) 4
Cortisone substitution (n) 3
Hypertension (n) 15
Diabetes type 2 (n) 3
Cardiac failure 1

GH, growth hormone; n, numbers.